Back
Redhill Biopharma Vs. Can Fite Biofarma Industry Stock Comparison
Sell
15
RDHL
Redhill Biopharma
Last Price:
7.13
Seasonality Move:
-5.95%
Sell
42
CANF
Can Fite Biofarma
Last Price:
1.58
Seasonality Move:
-13.05%
Sell
15
Redhill Biopharma (RDHL)
is a Sell
Is Redhill Biopharma a Buy, Sell or Hold?
- The current Redhill Biopharma [RDHL] share price is $7.12. The Score for RDHL is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
- RDHL is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
42
Can Fite Biofarma (CANF)
is a Sell
Is Can Fite Biofarma a Buy, Sell or Hold?
- The current Can Fite Biofarma [CANF] share price is $1.62. The Score for CANF is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
- CANF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
RDHL Stock Price Chart
What is Redhill Biopharma's stock price today?
-
The Redhill Biopharma share price today is $7.12
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RDHL is experiencing selling pressure, which indicates risk of future bearish movement.
CANF Stock Price Chart
What is Can Fite Biofarma's stock price today?
-
The Can Fite Biofarma share price today is $1.62
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CANF is experiencing slight buying pressure.
RDHL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.09 | Sell |
Relative Strength Index (14 RSI): | 44.04 | Sell |
Chaikin Money Flow: | -41690 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (6.94 - 8.06) | Sell |
Bollinger Bands (100): | (7.12 - 10.7) | Sell |
CANF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.16 | Sell |
Relative Strength Index (14 RSI): | 33.73 | Sell |
Chaikin Money Flow: | 112870 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.74 - 2.16) | Sell |
Bollinger Bands (100): | (1.89 - 2.81) | Sell |
RDHL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 7.6 | Sell |
20-day SMA: | 7.4 | Sell |
50-day SMA: | 7.85 | Sell |
200-day SMA: | 10.12 | Sell |
8-day EMA: | 7.54 | Sell |
20-day EMA: | 7.59 | Sell |
50-day EMA: | 7.98 | Sell |
200-day EMA: | 21.16 | Sell |
CANF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.71 | Sell |
20-day SMA: | 1.91 | Sell |
50-day SMA: | 2.15 | Sell |
200-day SMA: | 2.39 | Sell |
8-day EMA: | 1.7 | Sell |
20-day EMA: | 1.87 | Sell |
50-day EMA: | 2.08 | Sell |
200-day EMA: | 2.38 | Sell |
Redhill Biopharma Earnings Growth & RDHL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Can Fite Biofarma Earnings Growth & CANF Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.20 per share, and a decrease next year of $0.10 per share.
Redhill Biopharma Technical Analysis
Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Can Fite Biofarma Technical Analysis
Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |